rs775057540
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_006393.3(NEBL):c.903+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000094 in 1,595,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006393.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251052Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135668
GnomAD4 exome AF: 0.00000554 AC: 8AN: 1443334Hom.: 0 Cov.: 31 AF XY: 0.00000556 AC XY: 4AN XY: 719112
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74328
ClinVar
Submissions by phenotype
not provided Uncertain:1
The c.903+1G>T variant in NEBL has been identified in 1 individual with dilated cardiomyopathy (DCM; LMM data) and has also been reported in ClinVar (Variation ID 229050). It has been identified in 0.017% (7/41444) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). This variant occurs within the canonical splice site (+/- 1,2) and is predicted to cause altered splicing leading to an abnormal or absent protein. While splice and other loss of function variants in NEBL have been reported in individuals with DCM (Purevjav 2010 PMID: 20951326), current evidence is not sufficient to establish with certainty whether loss of function is a disease mechanism for DCM. In summary, despite the predicted severe impact to the protein, the clinical significance of this variant is uncertain, and its frequency suggests that it is unlikely disease causing in the heterozygous state. ACMG/AMP Criteria applied: BS1_Supporting. -
Primary dilated cardiomyopathy Uncertain:1
This sequence change affects a donor splice site in intron 9 of the NEBL gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), however the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in NEBL cause disease. This variant is present in population databases (rs775057540, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with NEBL-related conditions. ClinVar contains an entry for this variant (Variation ID: 229050). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at